172 related articles for article (PubMed ID: 201408)
1. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
Bieber MM; Fuks Z; Kaplan HS
Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
[TBL] [Abstract][Full Text] [Related]
2. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
3. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
4. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
5. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
6. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
7. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
[TBL] [Abstract][Full Text] [Related]
8. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
Lang JM; Bigel P; Oberling F; Mayer S
Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
Panteghini M; Piccioli E; Migliorati T; Ruggeri G
Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
[TBL] [Abstract][Full Text] [Related]
10. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
11. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
[TBL] [Abstract][Full Text] [Related]
12. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
[TBL] [Abstract][Full Text] [Related]
13. [Role of splenectomy in impairing lymphocyte elimination in patients with lymphogranulomatosis].
Kuz'mina EG; Bogatyreva TI; Baĭsogolov GD; Iarilin AA
Vopr Onkol; 1986; 32(8):65-8. PubMed ID: 3765511
[TBL] [Abstract][Full Text] [Related]
14. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
15. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
17. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
18. The occurrence and properties of E rosette inhibitory substance in the sera of malnourished children.
Salimonu LS; Johnson AO; Williams AI; Adeleye GI; Osunkoya BO
Clin Exp Immunol; 1982 Mar; 47(3):626-34. PubMed ID: 6805988
[TBL] [Abstract][Full Text] [Related]
19. Ferritin-bearing lymphocytes in Hodgkin's disease.
Koprivová H; Hermanská Z; Novák F; Blehová Z; Dienstbier Z
Neoplasma; 1986; 33(1):63-9. PubMed ID: 3515213
[TBL] [Abstract][Full Text] [Related]
20. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]